American University in Cairo

AUC Knowledge Fountain
Theses and Dissertations

Student Research

2-1-2020

Analysis of single-cell RNA-Seq reveals dynamic changes during
macrophage state transition in atherosclerosis mouse model
Ahmed Safwat Abouhashem

Follow this and additional works at: https://fount.aucegypt.edu/etds

Recommended Citation

APA Citation
Abouhashem, A. (2020).Analysis of single-cell RNA-Seq reveals dynamic changes during macrophage
state transition in atherosclerosis mouse model [Master's Thesis, the American University in Cairo]. AUC
Knowledge Fountain.
https://fount.aucegypt.edu/etds/825

MLA Citation
Abouhashem, Ahmed Safwat. Analysis of single-cell RNA-Seq reveals dynamic changes during
macrophage state transition in atherosclerosis mouse model. 2020. American University in Cairo,
Master's Thesis. AUC Knowledge Fountain.
https://fount.aucegypt.edu/etds/825

This Master's Thesis is brought to you for free and open access by the Student Research at AUC Knowledge
Fountain. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of AUC
Knowledge Fountain. For more information, please contact thesisadmin@aucegypt.edu.

The American University in Cairo
School of Science and Engineering

Analysis of Single-Cell RNA-Seq Reveals
Dynamic Changes During Macrophage State
Transition in Atherosclerosis Mouse Model
A Thesis Submitted to the Biotechnology Program In Partial Fulfilment
of the Requirements for The Degree of Masters of Science in
Biotechnology
By: Ahmed Safwat Elsayed Abouhashem
Bachelor of Medicine, Bachelor of Surgery (MBBCh), Zagazig
University
Under the Supervision of Dr. Hassan Azzazy
Professor and Chairman
Department of Chemistry
The American University in Cairo
December 2019

Dedication
I dedicate this research to my family for always providing me the time and
facilities to focus on studying and research.

I

Acknowledgements
I would like to acknowledge the American University in Cairo, the
Department of Biology for providing me the resources and materials to improve my
knowledge. Also, I would like to acknowledge Indiana University, IUPUI, for
providing a variety of wonderful teams in different disciplines. In particular, I would
like to acknowledge Department of Surgery in Indiana University for their experience
and guidance which were vital to the project. Also, I would like to acknowledge Dr
Azzazy (AUC) for changing my mindset regarding how to identify problems and how
to find existing solutions that fit and Dr Sen and Kanhaiya (Indiana University) for
their continuous support from always appreciating my efforts to provide me with all
the facilities to translate my ideas into experimental and clinical research through
different lab members and multiple collaboration with other astonishing teams in
Indiana University. I would like to acknowledge Dr Sarath Janga (Indiana University)
for his guidance regarding interpreting the results. I would like to acknowledge Razan
Masad.

II

Abstract
Background: Atherosclerosis is an arterial inflammation that causes ischemic
heart disease, which is the first leading cause of death worldwide. Macrophages play
major roles during disease development by having pro-inflammatory and antiinflammatory functions. Lack of effective treatment is mainly due to incomplete
understanding of the molecular mechanisms underlying disease progression and
regression.
Materials and methods: The transcripts of the macrophages from two aortic
samples from atherosclerotic region during disease progression and regression were
analyzed using previously published dataset (GEO Accession GSE123587). Preprocessing, clustering of cells and identification of unique markers for each cluster
were done using Seurat package implemented in R programming language. Monocle
package was used to order the cells in pseudotime and to detect the key molecules that
changed dramatically during comparison between distinct macrophages states (proinflammatory and anti-inflammatory). Ingenuity Pathway Analysis (IPA) software
was used to analyze the pathways activity across macrophage states along the
trajectory and to retrieve the transcriptional regulatory network between the genes
determining the final states. Prediction of the miRNAs that might be involved in the
disease progression was performed using TargetScan and GSEA (Gene Set
Enrichment Analysis). Cytoscape application was used to visualize the regulatory
network between the differentially regulated genes across macrophages states.
Results: Clustering analysis of macrophages revealed their presence in
distinct 11 states. In addition, Two states were found to be dominant in the
progression group macrophages, and one state was found to be dominant in the
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regression group macrophages. Moreover, trajectory analysis showed a bifurcation
point near the end of the trajectory, where macrophages fates were destined to be
either pro-inflammatory or anti-inflammatory. Macrophages unique to the disease
progression branch were found to activate STAT cascade, induce acute inflammatory
response and upregulate inflammatory cytokines, denoting M1 polarization. In
contrast, regression-branch specific macrophages were found to activate cholesterol
efflux pathways and upregulate anti-inflammatory cytokines such as TSLP and
CCL24. The transcription regulatory network between differentially regulated genes
in both branches revealed changes in the transcriptional dynamics acquired during
macrophage states transition. STAT1 (Signal transducer and activator of transcription
1) and IRF7 (Interferon Regulatory Factor 7) were found to be upregulated in the
progression branch to maintain an inflammatory module resulting in production of
distinct inflammatory cytokines. On the other hand, MAFB (MAF BZIP Transcription
Factor B) and IGF1 (Insulin-like growth factor 1) were found to be upregulated in the
regression branch to interrupt the inflammatory module at different levels. In addition,
10 miRNAs were predicted to be unregulated in progression-branch specific
macrophages such as miR-344, miR-346 and miR-485.
Conclusion: Inflammatory sites in atherosclerosis lesions contain both proinflammatory and anti-inflammatory macrophages. Each subset of macrophage
activates unique transcriptional program. Certain transcription factors and growth
factors have potential to alter the whole transcriptional regulatory network, thereby
shifting

the

macrophages

from

inflammatory

to

anti-inflammatory

state.

Understanding how macrophage state transition occurs from inflammatory to antiinflammatory state will be a key step to better understanding and treating
atherosclerosis.
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CHAPTER 1: Introduction
1.1 Atherosclerosis
1.1.1 Epidemiology and Statistics
Atherosclerosis is a chronic inflammation of the arteries, which is initiated by
low density lipoprotein (LDL) accumulation in defined regions in the arteries where
the blood flow is disturbed and non-laminar. Atherosclerosis results in stroke, heart
attacks and peripheral arterial disease (Dichgans M et al., 2019; Mohd Nor NS et al.,
2019; Paul S et al., 2019). It is the major cause of cardiovascular diseases resulting in
ischemic heart disease and ischemic stroke, which are the first and fifth causes of
death worldwide; respectively (Ala-Korpela M et al., 2019; Watson M et al., 2019;
Whelton SP et al., 2019; Carmona FD et al., 2019).
1.1.2 Aetiology and Pathophysiology
Multiple risk factors are involved in the development of atherosclerosis. The
most common factors include elevated blood LDL (hypercholesterolaemia), diabetes
mellitus, hypertension, smoking, sex as a male, old age (more than 45 years for males
and more than 55 years for females) and family history of the disease (Reiss AB et
al., 2019; Shafi S et al., 2019; Doodnauth SA et al., 2019). Atherosclerosis
development started with endothelial cells dysfunction and infiltration of immune
cells in the lesion micro-environment, resulting from arterial wall injury (figure 1).
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Figure 1. Atherosclerosis resulting from chronic arterial wall injury. Chronic
inflammation of endothelial cells resulting from atherosclerotic risk factors induces
endothelial cells dysfunction and alteres the arterial wall micro-environment.
Macrophages recruitment to the lesion site results in foam cell formation after
engulfing the deposited lipids in the arterial wall intima. Reproduced with permission
(Rafieian-Kopaei et al., 2014). Image Source Reference; Copyright; see appendix.

Atherosclerosis is a continuous process of arterial wall lesions caused by lipid
retention in the intimal part of the artery, which results in aggravation of the chronic
inflammation. Following lipid retention, the intima develops fibrous plaques,
resulting in disease complications such as stenosis or remote vessel occlusion due to
rupture of the fibrotic plaque. Mechanisms of plaque rupture include shear stress
injury (Gertz S et al., 1990), transient collapse of the stenotic lesion (Binns R et al.,
1989) mechanical shear injury (Vito R et al., 1990) and vasa vasorum rupture (Barger
A et al., 1991).
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1.1.3 Immune Cells in Atherosclerotic Plaques
Atherosclerotic plaques contain several immune cells, including dendritic
cells, macrophages and platelets (Libby et al., 2013). Dendritic cells have been found
to increase dramatically as the disease progresses in the atherosclerotic plaques
(Galkina E et al., 2006). They produce distinct chemokines in the lesion area resulting
in recruiting lymphocytes and monocytes to the inflammation micro-environment
(Huang DR, et al., 2001).
Macrophages in the plaque sites originate either from recruitment of blood
circulating monocytes or from proliferation of tissue resident macrophages (Ginhoux
and Jung, 2014). Macrophages have been found to play dual roles in the development
of atherosclerosis as both of the phenotypes (M1 and M2) were found in
atherosclerotic plaques (figure 2, 3) (Bouhlel et al., 2007 , De Paoli et al., 2014).
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Figure 2. Distinct phenotypes of macrophages during atherosclerotic plaque
development. During early stages of the disease development, activation of
endothelial cells occur. Following endothelial cells activation, monocytes are
recruited into the lesion micro-environment and differentiated into macrophages.
Distinct states of macrophages are found in the lesion site playing either
inflammatory (M1 phenotype) or anti-inflammatory (M2 phenotype) roles.
(Reproduced with permission (Sai Yang et al., 2019). Image Source Reference;
Copyright; see appendix.
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Figure 3. Macrophages phenotypes M1 and M2 roles during inflammation and
resolution. M1 phenotype is present during early stages of inflammation having roles
in inducing inflammatory response. On the other hand, M2 phenotype is present
during late stages of inflammation inducing resolution of the inflammatory response.
Reproduced with permission (Amitava Das et al., 2015). Image Source Reference;
Copyright; see appendix.

Pro-inflammatory (M1) macrophages have been found during plaque growth
causing inflammation. They ingest lipid particles and form foam cells where their
cytoplasm is filled with lipid droplets. Those foam cells secrete various signalling
molecules and pro-inflammatory cytokines to further recruit monocytes, cause more
lipid retention and result in extracellular matrix remodelling (Libby, 2002; Orekhov et
al., 2014). On the other hand, anti-inflammatory macrophages (M2) have been found
in the lesion area causing plaque regression and inflammation resolution (Nathan and
Ding, 2010). Furthermore, M2 phenotype cells are more resistant to form foam cells
and they contain fewer lipid droplets, indicating distinct metabolic activity between
both phenotypes (Chinetti-Gbaguidi et al., 2011).
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1.1.4 Integrin Signalling in Atherosclerotic Plaque Development
Distinct subsets of integrins have been found to be expressed by leukocytes
and white blood cells to mediate their interaction with the endothelial surface markers
(Hynes RO., 2002). These integrins have roles in the initial targeting leukocytes to
the inflammation site, facilitating their migration along endothelial cells into the
neointimal matrix (Ley K, et al., 2007) and regulation of their function upon
transendothelial migration into the inflammation micro-environment (Libby P et al.,
2015). Initial weak bonds are formed between integrins expressed by leukocytes and
selectins present on the endothelial cell surface. Notably, Atherosclerotic plaque
formation reduces dramatically following selectins deletion (Collins RG et al., 2000;
Dong ZM et al., 2000). Following integrins activation, leukocytes make rolling
movements resulting in firm cell adhesion and chemokines arrest on the endothelial
surface (Shamri R et al., 2005). The resulting increase in chemokines induces
inflammation and aid in further recruiting of more leukocytes (Boring L et al., 1998).
1.1.5 Cytokines and Their Role in Atherosclerosis Development
Cytokines are low-molecular weight proteins that are clustered into several
groups as interleukins, tumour necrosis factors, interferons (IFN), transforming
growth factors, chemokines and colony-stimulating factors. They are expressed in the
atherosclerotic plaques by almost all the cells in the lesion micro-environment having
either pro-inflammatory or anti-inflammatory role (Kleemann R et al., 2008;
McLaren J.E et al., 2011; Ait-Oufella H et al., 2011). Cytokines and chemokines are
potent signaling molecules mediating intercellular communication (Dinarello, 2007).
During initial stages of the disease development, cytokines have a role in modulating
endothelial cells permeability resulting in activating and opening up gaps between
cells (Pober J.S. et al., 2007). The activated endothelial cells release chemokines
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(chemoattractant cytokines) causing further recruitment of circulating leukocytes
especially monocytes and T cells (McLaren J.E. et al., 2011). Chemoattractant
chemokines modulate diverse intra-signalling pathways upon interaction with cell
surface receptors involving activation of G proteins (Koenen R et al., 2010; Weber C
et al., 2011).
1.1.5 Treatment and Management
Management of atherosclerosis is mainly by treating the risk factors as
elevated blood LDL, diabetes and others. Patients are advised to eat healthy diet
containing low saturated fat and less salts. In addition, they are encouraged to
exercise 90 to 150 minutes per day. Furthermore, drugs such as statins are used to
lower LDL cholesterol and reduce complications. Statins are a group of cholesterollowering compounds which act by inhibiting Hydroxymethylglutaryl Coenzyme A
Reductase (HMG-CoA). This inhibition reduces the rate by which the enzyme is able
to produce mevalonate, which is a major molecule in the cascade that produces
cholesterol (Endo A, 1992). Although statins can lower blood cholesterol level, they
have side effects such as muscle pain and abnormal blood levels of liver enzymes
(Abd TT et al., 2011). In severe stenosis, surgical intervention is recommended such
as coronary artery bypass grafting (Perez-Martinez P et al., 2019; Spannella F et al.,
2019; Esper RJ et al., 2019; Arnett DK et al., 2019). The complicated roles of
macrophages in atherosclerotic plaque micro-environment is poorly understood.
Thus, better understanding of the molecular alterations caused by macrophages in the
atherosclerotic plaque site is needed for improving the disease treatment.

7

1.2 Reverse Cholesterol Transport in Macrophages
Reverse cholesterol transport (RCT) was first described by Glomset (Glomset
JA, 1968) as the process of returning the excess circulatory cholesterol to liver. RCT
relationship with atherosclerosis development was first hypothesized as an imbalance
which occurs between arterial cholesterol deposition and removal (Ross R & Glomset
JA, 1973). In atherosclerotic plaques, macrophages are the primary cell type that are
overloaded with cholesterol (Tall AR, 2001). Macrophages take up the dead cells that
contain much cholesterol, lipoproteins and cellular debris (Rader DJ, 2005). The
unesterified cholesterol has toxicity effect on macrophages leading to apoptosis (abas
I, 2004). Thus, esterification of cholesterol to cholesteryl ester (CE) is the first line of
defense against cholesterol toxicity in macrophages by the enzyme ACAT1
(acyl:coenzyme A cholesterol O-acyltransferase-1) (Chang TY, 2001). Cholesterol
ester is stored in the cytoplasm and its accumulation results in foam cell formation.
The second line of defence against cholesterol toxicity is the cholesterol
efflux. ABCA1 is an active cholesterol efflux pathway and its knock out in mice
results in development of accelerated atherosclerosis (Aiello RJ, 2002). However,
alternative pathways by which macrophages can be able to induce cholesterol efflux
exist. ABCG1 was identified to promote cholesterol efflux in the form of HDL
particles and its knock out results in intracellular lipid accumulation (Kennedy MA,
2005). Both ABCA1 and ABCG1 are regulated by the nuclear receptors liver X
receptor LXR-α and LXR-β (Tontonoz P, 2003). Excess intracellular cholesterol
induces formation of oxysterol which are the ligands for liver X receptors (Repa JJ,
2002). Thus, excess cholesterol upregulates major pathways for cholesterol efflux
through ABCA1 and ABCG1 to protect the cells from the toxicity. Moreover, mice
deficient in LXR-α/-β have been found to have lipid accumulation within
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macrophages and tissues and have advanced atherosclerosis (Tangirala RK, 2002).
Furthermore, peroxisome proliferator–activated receptor PPAR-α and PPAR-γ
agonists were found to induce cholesterol efflux from macrophages through
upregulation of LXRs (Chinetti G, 2001 ; Li AC, 2004; Chawla A, 2001). Following
unesterified cholesterol efflux from macrophages, it associates with plasma HDL.
Then, lecithin:cholesterol acyltransferase (LCAT) catalyzes its esterification to
cholesteryl ester (CE) (Fielding CJ, 1995). As CE is hydrophobic, it moves to the
lipoprotein particle core allowing mature HDL formation. LCAT-deficient mice were
found to have very low level of HDL (Rader DJ, 1994) and its overexpression
resulted in high HDL level and reduction in atherosclerosis (Hoeg JM, 1996).
1.3 Macrophages plasticity and polarization
Macrophages are plastic cells which can switch their state from one phenotype
to another (Mantovani et al., 2004; Sica & Mantovani, 2012). Polarization of
macrophages is a process in which macrophages change their transcriptional program
in response to stimuli and signals from the surrounding micro-environment (Sica &
Mantovani, 2012). Several classes of macrophages have been described based on
their metabolic activity, surface markers expression and their released molecules. The
two

major

sub-populations

with

opposing

functions

are

M1

phenotype

(inflammatory) and M2 phenotype (anti-inflammatory). The phenomenon of
macrophages can change their state from M1 to M2 and the opposite is referred to
term “macrophage polarization” (Cassetta, Cassol & Poli, 2011; Chittezhath et al.,
2012).
M1 macrophages are induced by Th1 cytokines (IFN‐γ and TNF‐α) and they
produce pro-inflammatory cytokines such as TNFα, IL1α, IL1β and IL6 (Biswas et
al., 2012 ; Bashir et al., 2016). On the other hand, M2 macrophages are induced by
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Th2 cytokines (Wang et al., 2014) and have anti-inflammatory roles. However, the
M1/M2 phenotype does not reflect the distinct subsets of macrophages. They can be
further subdivided into different sub-types (Chistiakov et al., 2015). Recent advances
in single cell RNA-sequencing enables identification of phenotypes not previously
identified (Hannah Van Hove et al., 2019; Jian-Da Lin et al., 2019).
1.4 miRNA in Atherosclerosis
miRNAs are small non-coding RNAs, ~22 nucleotides in length. Biogenesis
of miRNAs starts with processing of RNA polymerase II/III transcripts mostly from
introns and few from exons and intergenic regions (Ha M et al., 2014; de Rie D et al.,
2017). miRNAs biogenesis is classified into canonical and non-canonical pathways.
The canonical biogenesis pathway is the dominant pathway in which the pri-miRNAs
are transcribed and processed into pre-miRNAs. Processing of pre-miRNAs are
performed by the microprocessor complex (DGCR8 , RNA binding protein DiGeorge
Syndrome Critical Region 8 and Dorsha, a ribonuclease III enzyme) (Denli AM et al.,
2004). DGCR8 recognizes motifs within the pre-miRNA (Alarcón CR et al. 2015)
and Drosha cleaves the pri-miRNA resulting in formation of a 2 nt 3′ overhang on
pre-miRNA (Han J et al., 2004). Then, the pre-miRNA is exported to the cytoplasm
by exportin 5 (XPO5)/RanGTP complex and further processed by the RNase III
endonuclease Dicer resulting in formation of the mature miRNA (Okada C et al.,
2009). In addition, multiple non-canonical miRNA biogenesis pathways have been
discovered. They can be classified into Drosha/DGCR8-independent and Dicerindependent pathways.
miRNAs recognize and bind to the 3′ UTR of the target mRNAs inducing
translational repression and mRNA deadenylation and decapping (Huntzinger E et al.,
2011). They have roles in both production and clearance of lipoproteins. miR-122 is
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the first identified miRNA to have a role in lipoprotein metabolism (Esau C et al.,
2006). Furthermore, overexpression of miR-30 in mice resulted in hyperlipidaemia
and atherosclerosis development (Soh J et al., 2013). Other miRNAs have been
identified to alter cholesterol efflux by targeting ABCA1 including miR-33 (Gerin I et
al., 2010), miR-758 (Ramirez CM et al., 2011), miR-144 (De Aguiar Vallim TQ et
al., 2013). Thus, miRNAs have potential roles in atherosclerosis progression and
regression.
1.5 Single Cell RNA Sequencing
Cells express different transcriptional programs while being in different states
even in similar cell types (Huang S et al., 2009; Li L et al., 2010; Shalek A K et al.,
2014). The transient states in-between stable states are difficult to be detected using
traditional experimental methods such as bulk RNA sequencing. Fortunately, single
cell RNA Sequencing allows detection of cells in those transition states without the
needs of their purification. It enables studying the heterogeneity among similar
cellular populations (Montoro DT et al., 2018; Plasschaert LW et al., 2018).
Multiple steps are required to generate single-cell data from a biological
sample and different protocols can be used. Generally, the steps incorporate
dissociation of single cells, library constructions and sequencing (Vieth B et al., 2017;
Macosko EZ et al., 2015; Rostom R et al., 2017). Droplet-based methods such as 10x
Genomics (which was used in the original study) start with isolating each cell from
the sample and capturing it in a microfluidic droplet. Although multiple cells or
cellular debris can be captured within the same droplet, computational methods can
be applied to overcome this issue by detecting and excluding those cells. Each droplet
contains the necessary enzymes and chemicals to digest the cell membrane and
perform library construction by reverse transcription of mRNAs generated from the
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single cell. Additionally, each droplet contains a barcode of 16 nucleotide long which
labels all the mRNAs from this single cell. After library construction, all the cDNAs
from each single cell are labelled with a unique barcode and the libraries are pooled
together for sequencing.
1.6 Pseudotime
Pseudotime is an abstract unit of measurement as it measures how much
progress for each individual cell has been made through the process of state transition
between cells. For the macrophages in atherosclerotic plaque, they were found to be
in different states (Bouhlel et al., 2007; De Paoli et al., 2014). Monocle package in R
uses reversed graph embedding algorithm to learn the sequence of change in gene
expression each cell must go through across dynamic biological processes in single
cells experiments (Qi Mao et al., 2016; Xiaojie Qiu et al., 2017). Thus, it enables
constructing a pseudo-temporal path to order the cells based on the gradual
continuous change of their transcriptomes (Trapnell C et al., 2014; Haghverdi L et al.,
2016).

12

CHAPTER 2: Hypothesis and Objectives
2.1 Hypothesis
Macrophages play a vital role in atherosclerosis during progression and
regression phases of the disease. They are able to dramatically change their states
between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes. This results
in secretion of distinct set of cytokines and activation of different metabolic
programs, which affect their ability to digest the lipid particles in the inflammatory
micro-environment.
Therefore, it is hypothesized that using single cell RNA sequencing help in
identifying the molecular signature of the macrophages during disease progression
and regression, the change in pathways activity during macrophages transition across
different states and the key molecules which drive the transition decision for the
macrophages to be either in an inflammatory (M1) or an anti-inflammatory (M2)
state.
2.2 Objectives
1. To cluster macrophages from each sample into distinct states (11 states).
2. To detect the macrophages states unique to disease progression (2 states) or
regression (1 state).
3. To order the cells in pseudotime to detect the bifurcation points where
macrophages go through different fates.
4. To calculate the pathways activity in different fates across the pseudotime.
5. To identify the key genes that drive the macrophages to either state.
6. To predict the miRNAs that may be involved in states transition.
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CHAPTER 3: Materials and Methods
3.1 Data source
The data was obtained from the GEO (http://www.ncbi.nlm.nih.gov/geo)
under the accession number GSE123587. The data was produced by Jian-Da Lin et al,
a research group in USA in 2019 (Jian-Da Lin et al., 2019). Their paper is entitled
“Single-cell analysis of fatted-mapped macrophages reveals heterogeneity, including
stem-like properties, during atherosclerosis progression and regression”. The paper
was published in JCI Insight Journal, Volume 8, Issue 8, 2019. The original study
aimed to address the differentiation of CX3CR1+ CCR2+ cells into macrophages in
atherosclerotic plaques during progression and regression of the disease.
The authors generated a chimeras of LDLr-/- (LDL receptor) mice and placed
all the eight weeks old mice onto a Western diet (contains high fat content) for 18
weeks. Then, the mice were divided into two groups: a progression group which
continued on Western diet and a regression group which was switched to a chow diet
(less fat) and injected with apolipoprotein B (ApoB) anti-sense oligonucleotide
intraperitoneal (50mg/kg) twice per week to lower the atherogenic lipoproteins. After
2 weeks, they sorted the macrophages from the aortic arches of progression and
regression groups. This enabled excluding cells from lymphoid lineage such as T
cells, B cells, eosinophils, neutrophils and natural killer cells.
Then, the sorted cells were processed to single-cell RNA sequencing. Finally,
by combining four samples from each group with total number of 10,000 to 12,000
cells for each group, cells were loaded on 10x Genomics instrument and libraries
were prepared as described (GX et al., 2017). Then, the authors used CellRanger
Single Cell Software Suite (version 1.3) for processing the raw reads and generating
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the

count

matrix

(https://support.10xgenomics.com/single-cell-gene-

expression/software/pipelines/latest/what-is-cell-ranger).
3.2 Single Cell RNA-Seq Counts Matrix Pre-processing
The generated count matrix from the two samples was used to perform quality
check and further downstream analysis. Seurat package in R (v3.1.0) was used to
process the counts matrix, barcodes and genes for each sample (Stuart T et al., 2018;
Butler et al., 2018).
3.2.1 Data Integration
The data from the two samples was integrated to enable the identification of
common cellular states and to allow comparative analysis between them as described
in Butler et al., 2018. Briefly, integration of the two samples required multiple steps
starting from data normalization to identification and integration of anchors between
cells from the two samples. For normalization, log 10-transformation of expression
values for each gene was performed, using 10,000 molecules for each cell as a size
factor. Then, standardization of expression value of each gene across all the cells was
performed (linear transformation) to shift the expression of each gene, so that the
mean is 0 and the variance is 1 across all the cells. This gives equal weight, so that no
domination for the highly expressed genes in the downstream analysis.
The top 2000 highly variable genes in both samples were chosen to perform
canonical correlational analysis (CCA) and dimensionality reduction to detect cells
from the 2 samples with common biological states. K-nearest neighbours (KNNs)
were identified and each pair of cells from the two samples represent an anchor
(mutual nearest neighbours). Further filtering of anchors was performed by giving a
score to each anchor using shared nearest neighbour (SNNs) graphs between the two
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samples. Finally, small number of anchors surrounding each cell were considered for
identifying the integration anchors. The identified anchors and the weights matrix was
used to integrate the two samples as described in Haghverdi L et al., 2018.
3.2.2 Filtering low quality cells
As suggested before, there is a positive correlation between expression level
of mitochondrial encoded genes and cell death (Detmer SA et al., 2007; Galluzzi L et
al., 2012, Silvia Márquez-Jurado et al., 2018). Thus, cells that exhibit mitochondrial
contamination (more than 5% of the reads are mitochondrial encoded genes) were
filtered. Also, cells with very high or very low total number of gene counts (more
than 7000 or less than 2500) were filtered as high counts may represent cell doublets
or multiplets and low counts may represent empty droplets or represent premature cell
rupture leading to mRNA leakage.
Moreover, cells identified as non-macrophages were excluded from the
analysis. Identification of each cell type was performed using SingleR package
implemented in R (Aran D et al., 2019). The algorithm computes the similarity
between the dataset and a reference dataset for unbiased recognition of cell types. The
reference dataset chosen was ImmGen (Immunological Genome Project), which
includes 830 microarrays classified into 20 main cell types and 253 subtypes. Briefly,
Spearman coefficient was calculated for each cell expression with each of the
reference datasets samples. Then, correlation analysis was performed followed by
aggregation of multiple correlation coefficients per cell types using 80% percentile of
the correlation values. Next, the correlation analysis was rerun using only the top cell
lines resulted from the previous step and the variable genes between those cell types,
while removing the lowest cell type. Finally, the previous step was repeated until two
cell types remained and the top one was assigned to the cell.
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3.2.3 Dimensionality Reduction
Principal component analysis (PCA) was performed using the previously
identified 2000 highly variable genes in both samples. Each principal component
represents information about a correlated gene set. To further determine how many
principal components to be used for dimensionality reduction, Jackstraw procedure
was used (Chung NC et al., 2015). Jackstraw procedure is a resampling test, in which
a subset of the data is randomly permuted and PCA is rerun, allowing for construction
of a “null distribution” of genes scores. This method allows identification of the
significant PCs that have low p-values. In addition, a heuristic method based on the
percentage of variance represented by each gene was used to generate elbow plot.
Consequently, the first 24 principal components were chosen to reduce the data
dimensions for downstream analysis to enable using the highly variable genes instead
of using all the genes as features.
3.3 Clustering of Single Cells
A graph-based clustering approach was used for clustering the cells. Cells
were embedded in a graph structure (KNN graph) based on Euclidean distance in
PCA space. Then, edge weights were refined between any pair of cells based on
Jaccard similarity (the shared overlap between the cells local neighbourhoods). Edge
refinement was performed using the first 24 PCs as previously determined to be the
dimensionality of the data. After refinement edge weights, edges were drawn between
cells having similar gene expression patterns. Louvain algorithm was applied as a
modularity optimization technique to group cells together. Finally, Uniform Manifold
Approximation and Projection (UMAP) was used to visualize the cells using the
reduced dimensions (Becht et al., 2018; McInnes et al., 2018).
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3.4 Identification of Unique Markers for Each Cluster
To identify unique markers for each cluster, Seurat was used to perform
differential expression analysis by comparing each cluster with the rest of other
clusters using Wilcoxon Rank-Sum Test. Log2 fold change cut off value of ± 0.5 and
an adjusted p value less than 0.05 were used to detect the differentially expressed
genes within each cluster.
3.5 Constructing Single Cell Trajectories
Monocle package in R (v2.10.1) uses reversed graph embedding algorithms to
order the cells in pseudotime and construct the trajectory (Trapnell C et al., 2014).
The significant markers from all the clusters with log2 fold change ± 0.5 were used to
order the cells (437 genes). Briefly, the ordering algorithm reduces the data
dimensionality, learns the smooth manifold that generates the data and finally places
every cell at the proper position in the trajectory through unsupervised method. In
addition, if there are multiple outcomes, it reconstructs a branched tree representing
different cellular fates (Qi Mao et al., 2015).
3.6 Differential Expression Analysis of the Terminal Branches
Furthermore, Monocle enables detection of branch points along the trajectory.
The significant branch-dependent genes are the genes that explicit different
expression dynamics along each branch. Branched expression analysis modelling
(BEAM) algorithm implemented in Monocle, was used to find all the genes that
differ between the two terminal branches after the bifurcation point. Then,
hierarchical clustering of the resulting top 457 genes with (q value less than 1e10-4)
was

performed

for

further

downstream
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analysis.

Finally,

EnrichR

(https://amp.pharm.mssm.edu/Enrichr/) was used to enrich the identified clusters with
the significant gene ontology biological processes (Maxim V et al., 2016).
3.7 Pathway Activity Analysis
Pathway activity analysis was performed using Ingenuity Pathway Analysis
software

(IPA)

(QIAGEN

https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis).

Inc.,
The

algorithm considers the role of each gene within the pathway, so that each pathway
has a pattern to be considered fully activated. If the gene is consistent with its pattern
specific to pathway i, score of 1 is assigned to the gene in pathway i, and if it is
inconsistent, a score of -1 is assigned for this gene in pathway i. Finally, for
determining the activity of pathway i, Z score was calculated for each pathway in
each pseudotime point using the following equation, where z is the activation score:

Xi is the score of a gene in the pathway. N+ and N- are the number of the
consistent and inconsistent genes with the pathway pattern; respectively. N is the total
number of genes in pathway i. Then, the 457 genes differentially expressed between
the 2 branches were used with 20 pseudotime points representing the whole
pseudotime. The gene was considered upregulated or downregulated using cut off ±
0.5.
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3.8 Transcription Regulatory Network Analysis
The genes that were identified to be differentially expressed between the two
different fates of macrophages using BEAM algorithm (457 genes) were used to
construct the transcriptional regulatory network. First, IPA was used to retrieve the
experimentally validated relationships between the genes. Then, causal analysis was
performed using IPA software to detect the subnetworks consistent with the results as
previously described (Andreas et al., 2014). Finally, Cytoscape application was
applied to visualize the resulting network using the values of the last pseudotime
points from both branches (Shannon P et al., 2003).
3.9 miRNAs Prediction
TargetScan (http://www.targetscan.org/) was used to predict the miRNAs
that may play a role in regulating the expression level of the differentially regulated
genes in progression versus regression branch. The Predicted targets of all known
mouse miRNAs were downloaded based on their alignment with the 3’ untranslated
regions of each transcript (Rosenbloom KR et al., 2013; Agarwal V et al., 2015).
Then gene set enrichment analysis (GSEA) was performed using the gene
expression

data

at

the

end

of

the

progression

(http://software.broadinstitute.org/gsea/index.jsp) (Subramanian et al., 2005).
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branch

CHAPTER 4: RESULTS
The authors in the original study performed scRNA-seq using 10x Genomics
technology and performed the alignment using CellRanger software (Jian-Da Lin et
al., 2019). The goal of the current study is to start from performing the quality control
and clustering of the cells to trajectory inference, pathway activity analysis and
miRNA prediction (Figure 4).

Figure 4. The analysis workflow. Sequencing of single cells were performed using
10x Genomics technology. CellRanger was used for mapping of reads to the mouse
genome. Seurat package in R was used for pre-processing of the resulting count
matrix, clustering and identification of unique markers for each cluster. Then,
Monocle in R was used for trajectory inference and analysis of the bifurcation point.
The resulting differentially expressed genes were used for different downstream
analysis applications. EnrichR was used for GO biological processed enrichment of
the resulting clusters. Ingenuity Pathway Analysis (IPA) software was used to
analyse pathway activity over pseudotime and for retrieving the transcriptional
regulatory network. TargetScan was used along with Gene Set Enrichment
Analysis (GSEA) for miRNA prediction. Cytoscape was used for network
visualization.
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4.1 Pre-processing of Single Cell RNA Sequencing Counts Matrix
Data from a total number of 3157 cells for progression group and 2198 cells
for regression group were analysed. Using SingleR package, most of the cells were
identified as macrophages, while few number of cells were assigned to dendritic cells,
B cells, monocytes, stem cells and stromal cells. 1565 cells during atherosclerosis
progression and 1421 cells during atherosclerosis regression remained after excluding
cells with mitochondrial contamination, very high or low total counts and nonmacrophages cells (figure 5; figure 7-A & B; section 3.2.2 in methods).
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Figure 5. Quality check for single cells before and after filtering. (A) Violin plots
showing abundance of cells in each sample regarding the number of detected genes
(features), total number of gene counts per cell and the percentage of mitochondrial
genes expression (left: before filtering and right: after filtering). Each dot represents
one cell. (B & C) Scatter plots before and after filtering; respectively showing number
of gene counts against percentage of mitochondrial genes (left) and against total
number of detected genes per cell (right)
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Following log10-normalization and scaling of the gene counts, PCA was
performed using the top 2000 variable genes from both samples. Jackstraw procedure
was utilized to assign p value for each principal component as shown in figure 6-A.
Moreover, elbow plot was generated using a heuristic method based on the
percentage of variance represented by each gene as in figure 6-B. Analysis of the
principal components suggest that the majority of the signal was captured in PCs
from 1 to 24.

Figure 6. Principal component analysis of single cells. (A) Jackstraw plot
showing the first 50 principal components from the PCA analysis with their
corresponding p-values. (B) Elbow plot showing the standard deviation of the first 50
PCs.
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4.2 Clustering and Visualization
A graph-based clustering approach was performed to cluster the cells using
the first 24 principal components. Then, UMAP algorithm was used as a non-linear
dimensionality reduction technique to visualize the data as shown in figure 7-C.
Figure 7-D represents the percentage of the cells assigned to each cluster in respect to
each condition (progression and regression groups). Clusters with more than 100 cells
and represent more than 70% of their cells from either group were considered to be
condition-specific clusters. Cluster four consists of 71% of its cells from the
regression group, while 82% and 83% of clusters six and seven; respectively arose
from the progression group (Figure 7-D, table 1).
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Figure 7. Clustering of single cells and compositional analysis of the clusters. (A)
t-distributed stochastic neighbor embedding (t-SNE) projection of the raw data before
filtering (5355 cells) color-coded using a scale of gray to violet to plot the percentage
of mitochondrial genes (right), total number of gene counts per cell (left) and number
of unique genes per cell (middle) . Each cell is represented as a dot. (B) t-SNE plot of
all cells showing the cells which passed the quality control (green) and the excluded
cells (black) from the downstream analysis. (C) Uniform manifold approximation and
projection (UMAP) projection of the filtered cells showing 11 clusters in each
sample. (D) Compositional analysis of each cluster showing the percentage of the
cells from each group per cluster.
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Table 1. Number of cells assigned to each cluster in both samples
Cluster
number

Number of cells

Percentage

Progression

Regression

Total

Progression

Regression

Cluster 0

264

417

681

38.77

61.23

Cluster 1

321

278

599

53.59

46.41

Cluster 2

271

185

456

59.43

40.57

Cluster 3

191

133

324

58.95

41.05

Cluster 4

70

177

247

28.34

71.66

Cluster 5

72

120

192

37.50

62.50

Cluster 6

157

34

191

82.20

17.80

Cluster 7

122

25

147

82.99

17.01

Cluster 8

56

38

94

59.57

40.43

Cluster 9

32

6

38

84.21

15.79

Cluster 10

3

13

16

18.75

81.25

4.3 Identification of Clusters Markers
Seurat was used to compare each cluster with the rest of other clusters using
Wilcoxon Rank-Sum Test. Log2 fold change cut off value of ± 0.5 and adjusted p
value less than 0.05 were chosen to detect unique markers for each cluster, resulting
in a total number 437 genes for all the 11 clusters. Figure 8 represents the identified
markers from clusters four, six and seven.
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Figure 8. Heatmaps of the identified markers for clusters four, six and seven. (A)
Comparison of average expression of selected markers between cluster four
(regression-specific) and clusters six and seven (progression-specific). Markers are
classified into cytokines, transcription factors, enzymes, peptidases, transmembrane
proteins, transporters, phosphatases and kinases. High expression is represented by
red color, while low expression is represented by green color.
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4.4 Constructing and Analysis of Single Cell Trajectories
Monocle was used to order the cells in pseudotime and to construct the
trajectory using the previously identified markers (figure 9-A). Branched expression
analysis modelling (BEAM) algorithm was performed to find all the genes that differ
between the two branches after the bifurcation point. Then, hierarchical clustering of
the top differentially expressed genes resulted in nine clusters with distinct patterns
across the pseudotime (Figure 9-B). Figure 9-C represents the gene ontology
biological processes enrichment for the nine identified groups.
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Figure 9. Single-cell trajectory analysis and dynamic changes in gene expression
of branches-specific macrophages. (A) Cells along the trajectory are divided into
distinct stable states and ordered according to the pseudotime development along the
trajectory. At the branching point (highlighted with a black dot), cells divide to go
through two fates. Cells are colored based on their position across the pseudotime
(above) or based on the sample (below). (B) Heatmap of the top 457 differentially
expressed genes between the two branches represents the transcriptional dynamics
across the two branches. Genes (rows) are clustered and cells (columns) are ordered
according to the pseudotime development. The middle part of the heatmap shows the
pre-branch points and the outermost left and right parts show the regression and the
progression groups; respectively. (C) The patterns of each cluster from the heatmap
along with enrichment of the GO biological processes. All the enrichment terms have
p-value < 0.05 and the star denotes corrected p-value < 0.25.

31

4.5 Pathway Activity Analysis
IPA software was used to compute pathway activity analysis for both
branches. Figure 10-A represents a heatmap of the z scores for each pathway across
the pseudotime in both branches.
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Figure 10. Pathways and predicted miRNAs in macrophages across the
pseudotime (A) Heatmap showing each pathway activity across the pseudotime for
both the progression and regression branch-specific macrophages. The middle points
of the heatmap represent the pre-branching pseudotime points, while the left and right
outermost points represent the progression and regression-specific macrophages;
respectively. (B) Gene set enrichment analysis plots for the top significant enriched
miRNAs in the progression group. (C) The predicted upregulated miRNAs and their
target genes. Colors represent the upregulated (red) and downregulated (green) genes
along the trajectory in the progression branch-specific macrophages.
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4.6 Transcriptional Regulatory Network Analysis
The transcriptional regulatory network was retrieved from the IPA database
considering only the experimentally approved relationships between the differentially
expressed genes in both branches. Causal analysis were performed using the software
to detect the consistent subnetworks. Figure 11 B and C represent the identified
network with gene values from the last pseudotime point from the progression and
regression branches; respectively.
4.7 miRNA Prediction
Gene set enrichment analysis (GSEA) was performed for differentially
altered genes in both branches. The gene expression values from the last pseudotime
point in the progression branch was used to perform the enrichment. Ten miRNAs
were enriched with p value less than 0.05 and bonferroni corrected p value less than
0.1 as shown in figure 10-B.
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Figure 11. Transcriptional regulatory network showing inflammatory module in
progression-specific macrophages (A) UMAP plotting color-coded using a scale of
green to red to black to represent the gene expression level within each cluster (left).
The relationship between some genes of interest (right). The transcription regulatory
network in the last pseudotime point of progression group (B) and regression group
(C). High expression is represented by larger node size and red color, while lower
expression is represented by smaller size and blue color.
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Figure 12. Expression of genes responsible for the inflammatory and antiinflammatory response (A) Trajectory analysis of cells within clusters four, six and
seven. (B) Violin plots showing expression level of genes involved in maintaining the
inflammatory module in the main network. (C) Violin plots showing expression level
of genes involved in interrupting the inflammatory module.
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Figure 13. Expression level of downstream targets of STAT1 and IRF7 (A)
Violin plots showing expression level of downstream targets of IRF7 and STAT1 in
progression-specific clusters six and seven and in regression-specific cluster four. (B)
Subnetwork from the main transcriptional regulatory network in progression-branch
specific macrophages (left) and in regression-specific branch macrophages (right).
High expression is represented by larger node size and red color, while lower
expression is represented by smaller size and blue color.
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Figure 14. Altered downstream targets of MAFB gene MAFB and its downstream
targets in regression-specific macrophages (A) and progession-specific macrophages
(B). High expression is represented by larger node size and red color, while lower
expression is represented by smaller size and blue color.
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CHAPTER 5: DISCUSSION
5.1 Distinct States of Macrophages During Disease Progression and Regression
Previous studies to evaluate the macrophage population in atherosclerosis
demonstrated that symptomatic plaques contain macrophages of M1 inflammatory
phenotype (Cho KY et al., 2013). In contrast, M2 anti-inflammatory phenotype was
found to be enriched in asymptomatic lesions indicating the opposing role of
macrophages in disease progression and resolution (Monica de Gaetano et al., 2016).
Each phenotype stimulates distinct transcriptional program and differs regarding its
metabolic activities. For instance, inflammatory phenotype expresses surface markers
and secretes specific pro-inflammatory cytokines transmitting the inflammatory
signals to neighbour cells in the plaque micro-environment. Also, their transcriptional
state results in inefficient lipid metabolism enabling aggravating the inflammation
and foam cell formation, while the M2 phenotype expresses certain genes enabling
dampening the inflammation and prevention of intracellular lipid retention.
Clustering of macrophages from both samples resulted in identification of 11
clusters. Although, macrophages during disease progression and regression shared
common states, condition-specific clusters were identified. Cluster four was found to
be more abundant in the regression group (71%), while clusters six and seven were
abundant in the progression group, 82% and 83%; respectively, (figure 7-C, table 1).
The two clusters (six and seven) arose mainly during atherosclerosis progression
indicating their role in the inflammatory process. Moreover, trajectory inference
revealed two distinct fates of macrophages, where cluster four acquired a path differs
from that of clusters six and seven (figure 12-A). Furthermore, analysis of the
differentially regulated genes and pathways from those unique clusters revealed new
insights into the regulatory mechanisms underlying macrophages states during
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disease progression and regression. For instance, the upregulated genes along the
trajectory towards the progression branch-specific macrophages were enriched for
biological processes that enhance the disease progress (figure 9-C). They are enriched
for cholesterol storage, foam cell differentiation, STAT cascade, INF signalling and
positive regulation of acute inflammatory response. On the contrary, regression
branch-specific upregulated genes were enriched for bleb assembly and cholesterol
efflux indicating the existence of distinct transcriptional program and metabolic
activity for each group of macrophages.
5.2 Extracellular Matrix Remodelling
Pathways activity analysis revealed increase in integrin and actin cytoskeletal
signalling activity in the progression branch-specific macrophages while decrease in
their activity in the regression branch-specific macrophages as shown in figure 10-A.
Integrins are involved in the disease initiation and progression by mediating the
interaction with endothelial cell surface receptors (Hynes RO, 2002). Although, the
plaque extracellular matrix contains lipids and fibronectins (FN), the source of the
fibronectins which are one of the earliest proteins deposited in the plaque site is not
clear. Notably, deletion of FN alleles from mice significantly reduced the plaque size
and prevent formation of the fibrous cap which results in the disease complications.
(Ina Rohwedder et al., 2012).
Interestingly, there is inter-cluster communication as shown in the two unique
clusters for the progression group (cluster six and seven). progression-specific
clusters produce distinct kinds of inflammatory cytokines (figure 8) indicating their
cooperation to boost the inflammatory process. For instance, cluster six produces the
cytokine CCL2 and cluster seven expresses the G-protein coupled receptor CCR2, the
binding partner for CCL2 (figure 11-A). CCL2-CCR2 interaction stimulates signal
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transduction through CCR2 receptor resulting in overexpression of FN1 in cluster
seven and fibronectin deposition, which is one of the earliest signs during
atherosclerosis development. This finding indicates that a small subset of
macrophages is a source of the deposited fibronectin in the plaque microenvironment. On the other hand, the regression-specific macrophages (cluster four)
downregulates CCR2, so that no signal transduction can be stimulated even in the
presence of CCL2 in the lesion site. Consequently, identification of the possible
mechanisms of modulating ECM components by macrophages could help in better
understanding the disease progression.
5.3 Dendritic Cell Maturation in the Progression Branch
Dendritic cells (DCs) during initial stages of atherosclerosis have been found
to be accumulated dramatically in the plaques (Galkina E et al., 2006). Pathways
activity analysis reveals that dendritic cell maturation signaling is upregulated in the
progression branch and not in the regression branch (figure 10-A). In fact, DCs have
been found to be able to accumulate lipids resulting in disease progression (Paulson
KE et al., 2010) and produce distinct pro-inflammatory cytokines such as CCL2 and
CCL4 to further recruit monocytes in the lesion area. (Huang DR et al., 2001;
Braunersreuther V et al., 2007). Furthermore, CCR2, was found to be positively
correlated with DCs level in atherosclerotic plaque (Combadiere C et al., 2003;
Combadiere C et al., 2008; Liu P, 2008) which is higher in progression branch as
previously mentioned. However, the regression branch has low expression of the
transmembrane receptor CD74, resulting in inhibiting DCs motility in mice (FaureAndre G et al., 2008). Besides, mice lacking CD74 have marked reduction of the
atherosclerotic plaque development (Sun J et al., 2010). This investigation offers
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insight into a potential role of macrophages on activating and suppressing of dendritic
cells during atherosclerosis development.
5.4 Cytokines in Progression and Regression
Cytokines in atherosclerotic plaques have both pro-inflammatory and antiinflammatory roles (McLaren J E, 2011; Ait-Oufella H, 2011). The results revealed
upregulation of distinct set of cytokines in each branch. The progression branch
shows upregulation of CXCL1, CXCL2, CXCL10, CCL3 CCL4, CCL5, CCL7,
CCL9, CCL12, IL1B, IL6, IL1RN and IFNB1, while the regression branch shows
upregulation of TSLP, PF4 and CCL24 and downregulation of the progressionspecific cytokines (figure 8).
During initial stage of the disease where capturing and rolling of monocytes
occurs, CCL5 and CXCL1 interact with proteoglycans and P-selectins on endothelial
cells causing immobilization (Ley K et al., 2007; Moore K J et al., 2013; Soehnlein O
et al., 2013). Both genes (CCL5 and CXCL1) have higher RNA expression level in
the progression branch. Additionally, CCL5 deposition in the plaques promotes
monocyte arrest (Von Hundelshausen P et al., 2001) and knockout of Y-box bindingprotein 1 which regulates CCL5 expression level results in reduction of neointimal
formation in ApoE -/- mice models (Krohn R et al., 2007). CXCL10, CCL3, CCL7,
IFNB1 and IL1-Beta, which are higher in the progression branch, have been found to
be involved in atherosclerosis progression and their downregulation reduces the proinflammatory genes and atherosclerosis plaque burden (Kirii H et al., 2003; Heller E
A, 2006; Kennedy A et al., 2012; de Jager S C et al., 2013; Alexander M R et al.,
2012, Denes A et al., 2012; Ting-Ting Chang et al., 2016). Moreover, IL-6 injection
in ApoE -/- mice increases plaque size and pro-inflammatory cytokines, while its
inhibition enhances atherosclerosis via reducing plaque size, decreasing activation of
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endothelial cells and reducing monocytes recruitment (Huber S A et al., 1999, Madan
M et al., 2008).
Furthermore, CCL2 was found to be higher in the progression branch. In
addition to its role in recruiting leukocytes to the inflammation site, it represses the
expression of the molecules responsible for cholesterol efflux from the cells resulting
in impairment of reverse cholesterol transport mechanism (Weber C et al., 2011;
Huang C X et al., 2013). Additionally, Pro-inflammatory cytokines cause inhibition
of LXR (Liver X receptors) signaling disrupting cholesterol efflux and resulting in
foam cell formation. (Pascual-García M et al., 2013). LXR signalling was found to
have less activity in progression branch and more activity in regression branch from
the pathway activity analysis (figure 10-A).
On the other hand, among the three cytokines found to be upregulated in the
regression branch, thymic stromal lymphopoietin (TSLP) was found to attenuate
atherosclerosis development (Kunwu Tu et al., 2013) and to promote macrophages
polarization towards M2 phenotype (Debin et al., 2019). Additionally, it further
upregulates CD63 tetraspanin (Wang B et al., 2013) which was also found to be
secreted in M2 macrophages exosomes (Peiming Zheneg et al., 2018). The second
cytokine, CCL24, also has been shown to be expressed in M2 phenotypes (Martinez
FO et al., 2006). The functionality of the third cytokine (PF4) found in the regression
group awaits further investigation. Taken together, the results indicate the production
of

anti-inflammatory cytokines from the macrophages in the regression branch

driving the process of atherosclerosis resolution.
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5.5 Analysis of the Transcription Regulatory Network
5.5.1 Role of STAT1 and IRF7 in Maintaining the Inflammatory Module
The progression branch-specific macrophages activate a transcriptional
program resulted in producing distinct kinds of cytokines and other molecules
aggravating the inflammatory response in the atherosclerotic plaque lesion site as
shown in figure 11-B. Together, STAT1 and IRF7 transcription factors upregulate
multiple pro-inflammatory cytokines such as CXCL10 and CCL12 (Vogel SN et al.,
2003; Miyagawa F et al., 2016) and downregulate the cytokine TSLP which is
upregulated in the regression-specific macrophages. Moreover, they upregulate the
expression of three peptidases (PSMB8, PSMB9 and USP18), which play a part in the
immunoproteasome machinery system in immune cells (figure 13-A, B) (Barton LF
et al., 2002; Goubau D et al., 2009). Notably, immunoproteasome is required for
protein processing to present antigenic peptides on MHC class I molecules (Kloetzel
PM, 2004) and it was found to be involved in autoimmune diseases pathogenesis
(Gutcher I et al., 2007). In fact, peptidases upregulation in the progression branchspecific macrophages sheds light towards their involvement in the continuous
inflammatory process during atherosclerosis development.
Interestingly, STAT1 and IRF7 also upregulates interferon induced proteins
and IFIT family proteins (Interferon Induced Protein with Tetratricopeptide Repeats)
as shown in figure 11 and 13-A. IFIT family members were found to be expressed
during viral infection and following IFN treatment (Diamond et al., 2012). They have
unique structure as they lack any enzymatic domains or activity. Rather, they have
multiple copies of TPR motif (tetratricopeptide), whose presence in proteins indicates
their role in cell cycle regulation, protein folding and protein transport. (D’Andrea LD
et al., 2003). IFIT proteins role in inflammation has contradicting results. Some
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studies reported their role in reducing the inflammation (Berchtold S et al., 2008; Li
Y et al., 2009), while others reported their role in augmenting the inflammatory
response. (McDermott JE et al., 2012). Recently, IFIT1, IFIT2 and IFIT3 were found
to be severely upregulated in M1 phenotype macrophages (Huang C et al., 2018),
indicating their role in inflammatory response. Accordingly, this investigation suggest
that IFIT family proteins might have a role in atherosclerosis development. In
addition, IFI35 has been previously identified to have a role in neointimal formation
and to serve in endothelial cell migration and proliferation (Jian D et al., 2018).
Moreover, interferon-stimulated exonucleases (ISG15 and ISG20) and IFI44
upregulation by IRF7 (Lazear HM et al., 2013) in atherosclerosis needs further
investigation as they show high expression level in progression-specific macrophages
(figure 13-A).
Surprisingly, once the inflammatory module is initiated, distinct feed-forward
loops and trans-activation patterns between STAT1 and IRF7 have been developed to
maintain the inflammatory process (Figure 11-B), while inhibiting the expression of
other cytokines such as TSLP that was found to be upregulated in the regression
branch-specific macrophages.
5.5.2 Interrupting the Inflammatory Module
On the contrary, regression branch-specific macrophages interrupt the
inflammatory network at multiple levels as seen in figure 11-C. Macrophages in the
regression branch show early downregulation of the transcription factor ID2
(Inhibitor of DNA binding 2), which has been reported to upregulate IRF5 (Li J et al.,
2017), preventing its downstream upregulation of IRF7, IFNB1 and STAT1 (Lazear
HM et al., 2013; Steinhagen F et al., 2015). Additionally, upon upregulation of IGF1
by S1PR1 stimulation (Straub AC et al., 2009), signal transduction through IGF1

47

interrupts the inflammatory network in multiple ways. For instance, IGF1
downregulates a number of pro-inflammatory cytokines CCL3, IL6 and IL1B as
shown on figure 11-C (Santini MP et al., 2007; Chand HS et al., 2012). Furthermore,
IGF1 can downregulate STAT1 downstream targets such as PSMB8 and PSMB9 (the
immunoproteasome subunits) (Pan Y et al., 2013) indicating their involvement in the
disease progression (figure 13-B).
Likewise, upregulation of IGF1 further results in breaking the inflammatory
module by decreasing activation of STAT1 and by inhibiting expression of IL6
(Bernabei P et al., 2003). IL6 inhibition resulted in upregulation of the antiinflammatory cytokine TSLP through downregulation of its inhibitor CCR2 (Bromley
SK et al., 2013). Consequently, TSLP upregulates the expression of the M2
macrophage surface marker CD63 denoting polarization towards M2 antiinflammatory phenotype (Wang B et al., 2013).
The analysis of the transcriptional regulatory network offers new insights into
potential roles of different transcription factors, growth factors and signal
transduction through G-protein coupled receptors in controlling expression of a wide
range of genes differentially expressed in macrophages in both branches.
5.5.3 Role of MAFB in Atherosclerosis
MAFB is a basic leucine zipper transcription factor involved in development
and lineage-specific hematopoiesis. (Kelly et al., 2000). It has been reported that
MAFB drives macrophages to M2 anti-inflammatory phenotype by altering various
number of inflammatory related genes (Víctor D et al., 2017) as shown in figure 14A. MAFB upregulates the solute carrier SLC40a1 (Ferroportin-1) which has a role in
iron efflux from the cells. Indeed, deposition of iron in atherosclerotic lesion occurs
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following intra-plaque haemorrhage (Kolodgie, F D et al., 2003). SLC40a1 was found
to be downregulated in the macrophages from the progression branch indicating loss
of their ability to export iron outside the cell. Consequently, overloading with iron
catalyses reactive oxygen species generation and lipid oxidation in the foam cells,
which in turn aids in further progression of the disease (Ramakrishna G et al., 2003).
Additionally, macrophages enriched with CD163 in atherosclerotic plaques were
found to have less lipid contents and less oxidative damage (Finn et al., 2012).
5.6 Role of the predicted miRNAs
Ten miRNAs were predicted to be upregulated to cause such alteration in the
gene expression in the progression branch-specific macrophages as shown in figure
10-B. Some of them were previously identified to play a role in atherosclerosis
progression. The role of miRNA-155 in atherosclerosis remains controversial as some
studies reported that its overexpression in ApoE -/- mice reduces the atherosclerosis
(Zhu et al., 2012) and others reported that its deficiency reduces the lesion size in
ApoE-/- mice (Nazari-Jahantigh et al., 2012). Recently, it has been reported that mice
with ApoE-/- / miR-155-/- double knockout have less atherosclerotic lesion (Anthony
Virtue et al., 2017). The exact role of miR-155 in atherosclerosis is not clear. The
results indicate that miR-155 can bind to the 3’ untranslated region of multiple
mRNAs suppressing the expression of a variety of genes such as LRP1, TGFBR2,
NRP1 and MAFB (figure 10-C). Mutation of LRP1 (Low-Density Lipoprotein
Receptor-Related Protein 6) was found to cause a number of metabolic diseases such
as hyperlipedemia, type 2 diabetes (Mani A. et al 2007). Particularly, LRP6 mutation
is associated with increase plasma LDL level (Tomaszewski M et al., 2009) which is
one of the major risk factor of atherosclerosis development. NRP1 (Neuropilin 1)
deficiency shifts the energy metabolism of macrophages towards glycolysis (Ariel
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Molly Wilson et al., 2018) as in the M1 phenotype resulting in more lactate and
reactive-oxygen species production and consequently more inflammation and
inefficient fatty acids burning (West AP et al., 2011).
ABCA1 (ATP Binding Cassette Subfamily A. Member 1) was predicted to be
targeted with miR-148, miR-140 and miR-758. ABCA1 was previously identified to
stimulate cholesterol efflux (Wang N et al., 2000, Oram JF et al., 2000). Mutations of
ABCA1 resulted in increasing cholesterol deposition in cells and tissues, especially in
macrophages (Assmann et al., 1995) and a significant reduction in plasma HDL level
(Marcil M et al., 1999). Anti-miR-148a shows reduction in the atherosclerotic plaque
formation (Rotllan N et al., 2018). MiR-410 inhibition was found to rescue
endothelial cells apoptosis by regulating oxidized-LDL levels (Ming-Yan Hu et al.,
2018). MiR-758 was identified before to target ABCA1 resulting in suppressing
cholesterol efflux from the cell (Ramirez CM et al., 2011)
IGF1, MAF and MAFB have been identified to be targeted with the predicted
miRNAs, resulting in suppressing their role in resolving the inflammation in the
progression-specific macrophages.
MiR-129-5p upregulation was suggested to have a protective role in
atherosclerosis through suppression of endothelial cell autophagy (Zhaohua Geng et
al., 2016), which was predicted in the results to be upregulated in the progressionspecific macrophages. This contradicting finding needs further validation.
The miRNAs prediction results confirmed the previously identified findings
from the literatures and revealed additional roles of those miRNAs. In addition, the
results offer new insights on other miRNAs involvement in the disease progression
such as miR-344-3p, miR-346 and miR-485-5p.
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CHAPTER 6: CONCLUSION AND FUTURE PERSPECTIVES
6.1 Conclusion
Atherosclerosis inflammatory sites contain both pro-inflammatory and antiinflammatory macrophages.

Each

subset

of macrophage

activates

unique

transcriptional program with distinct pathways and metabolic activities. Activating
integrin signalling and maturation of dendritic cells by the inflammatory macrophages
aggravates the inflammation by ECM remodelling. Inflammatory macrophages
express distinct set of genes to activate an inflammatory module aggravating the
atherosclerosis inflammation and disrupting cholesterol metabolism resulting in
intracellular cholesterol retention and foam cell differentiation. By upregulating
certain genes such as STAT1 and IRF7, macrophages can activate various pathways
to produce inflammatory cytokines which have positive regulatory effects on those
genes to maintain the inflammatory process. In contrary, upregulation of genes
responsible for cholesterol efflux and prevention of foam cell formation were found
in the anti-inflammatory macrophages. In addition, interrupting the inflammatory
module in M2 macrophages can be achieved by altering expression level of certain
transcription factors and key genes that act systematically to dampen the
inflammatory network by interrupting it at various levels. Anti-inflammatory
macrophages upregulates IGF1 and MAFB and downregulate ID2 transcription
factor, which in turn interrupt the inflammatory network through downregulating
STAT1, IRF7, IL6, IL1B and their targets as well. Understanding how antiinflammatory macrophages suppress inflammation is a key step to better understand
atherosclerosis resolution and offers new insights on how to force the transition of
macrophages from inflammatory phenotype to anti-inflammatory phenotype.
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6.2 Future Perspectives
This study has some limitations regarding the validation of the detected
candidates and the techniques used. It is limited to the computational analysis of
distinct macrophage states during atherosclerosis progression and regression. Future
work to experimentally validate the candidates is required. Additionally, although
single cell RNA sequencing allows detection of the heterogeneity among the total
population, the technique has shallow coverage and not like deep bulk RNA
sequencing. For instance, the average number of genes detected per cell is ranging
from 1000 to 2000 genes per cell in this dataset. Also, alternative splicing events are
difficult to be detected among the clusters because of the low number of reads per
gene in each cell. It is recommended for future studies to take into consideration
performing bulk RNA sequencing on cluster-basis. For instance, a combination of
unique surface markers can be identified for progression-specific clusters (cluster six
and seven) and the regression-specific one (cluster four) for sorting them and
performing deep RNA sequencing. This will extend the network analysis to include
more candidates and pathways that may be identified as therapeutic targets.
Furthermore, understanding how macrophages gradually change their states from
inflammatory to anti-inflammatory phenotypes can be used to force them to enter
anti-inflammatory state. Future research and experimental validations are required
using atherosclerotic mice models to confirm the findings.
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